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Abstract
The FANTOM5 consortium utilised cap analysis of gene expression (CAGE) to provide an
unprecedented insight into transcriptional regulation in human cells and tissues. In the current
study, we have used CAGE-based transcriptional profiling on an extended dense time course
of the response of human monocyte-derived macrophages grown in macrophage colony-
stimulating factor (CSF1) to bacterial lipopolysaccharide (LPS). We propose that this system
provides a model for the differentiation and adaptation of monocytes entering the intestinal
lamina propria. The response to LPS is shown to be a cascade of successive waves of tran-
sient gene expression extending over at least 48 hours, with hundreds of positive and nega-
tive regulatory loops. Promoter analysis using motif activity response analysis (MARA)
identified some of the transcription factors likely to be responsible for the temporal profile of
transcriptional activation. Each LPS-inducible locus was associated with multiple inducible
enhancers, and in each case, transient eRNA transcription at multiple sites detected by
CAGE preceded the appearance of promoter-associated transcripts. LPS-inducible long non-
coding RNAs were commonly associated with clusters of inducible enhancers. We used
these data to re-examine the hundreds of loci associated with susceptibility to inflammatory
bowel disease (IBD) in genome-wide association studies. Loci associated with IBD were
strongly and specifically (relative to rheumatoid arthritis and unrelated traits) enriched for pro-
moters that were regulated in monocyte differentiation or activation. Amongst previously-iden-
tified IBD susceptibility loci, the vast majority contained at least one promoter that was
regulated in CSF1-dependent monocyte-macrophage transitions and/or in response to LPS.
PLOS Genetics | DOI:10.1371/journal.pgen.1006641 March 6, 2017 1 / 36
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Baillie JK, Arner E, Daub C, De Hoon M,
Itoh M, Kawaji H, et al. (2017) Analysis of the
human monocyte-derived macrophage
transcriptome and response to lipopolysaccharide
provides new insights into genetic aetiology of
inflammatory bowel disease. PLoS Genet 13(3):
e1006641. doi:10.1371/journal.pgen.1006641
Editor: Judy H. Cho, Icahn School of Medicine at
Mount Sinai, UNITED STATES
Received: April 27, 2016
Accepted: February 17, 2017
Published: March 6, 2017
Copyright: © 2017 Baillie et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper, its Supporting Information files
and from http://fantom.gsc.riken.jp/zenbu/dex/,
with additional visualisations available from https://
coexpression.roslin.ed.ac.uk/lps
Funding: This study was supported by an Institute
Strategic Programme Grants (BB/G004013/1, BB/
I025328/1, BBS/E/D/20211550) from the
Biotechnology and Biological Sciences Research
Council to The Roslin Institute. JKB is funded by a
On this basis, we concluded that IBD loci are strongly-enriched for monocyte-specific genes,
and identified at least 134 additional candidate genes associated with IBD susceptibility from
reanalysis of published GWA studies. We propose that dysregulation of monocyte adaptation
to the environment of the gastrointestinal mucosa is the key process leading to inflammatory
bowel disease.
Author summary
Macrophages are immune cells that form the first line of defense against pathogens, but
also mediate tissue damage in inflammatory disease. Macrophages initiate inflammation
by recognising and responding to components of bacterial cells. Macrophages of the wall
of the gut are constantly replenished from the blood. Upon entering the intestine, newly-
arrived cells modulate their response to stimuli derived from the bacteria in the wall of the
gut. This process fails in chronic inflammatory bowel diseases (IBD). Both the major
forms of IBD, Crohn’s disease and ulcerative colitis, run in families. The inheritance is
complex, involving more than 200 different regions of the genome. We hypothesised that
the genetic risk of IBD is associated specifically with altered regulation of genes that con-
trol the development of macrophages. In this study, we used the comprehensive transcrip-
tome dataset produced by the FANTOM5 consortium to identify the sets of promoters
and enhancers that are involved in adaptation of macrophages to the gut wall, their
response to bacterial stimuli, and how their functions are integrated. A reanalysis of pub-
lished genome-wide association data based upon regulated genes in monocytes as candi-
dates strongly supports the view that susceptibility to IBD arises from a primary defect in
macrophage differentiation.
Introduction
Inflammatory bowel disease (IBD) comprises a group of complex syndromes that arise from a
dysfunctional interaction between the microbiota of the intestinal lumen and the immune sys-
tem [1]. Loci associated with the heritability of susceptibility to IBD are shared in some measure
with other chronic inflammatory diseases [2,3]. Extensive genome-wide association studies
(GWAS) have identified more than 200 risk loci for IBD, with significant overlaps between the
two major forms, Crohn’s disease and ulcerative colitis [4–6]. The analysis of candidate genes
within susceptibility loci based upon apparently shared biological function has emphasised
three major pathways: the activation of Th17 T cells, autophagy, and the response to mycobacte-
ria [7,8]. The emphasis on T cell activation derives in part from a clear association of susceptibil-
ity with certain MHC haplotypes, and the observed activation of T cells in inflamed mucosa [9].
An alternative view is that IBD is primarily initiated by functional dysregulation in cells of the
macrophage lineage [10,11] and prioritisation of candidates on that basis may be informative
[12].
By contrast to other tissue macrophage populations which have a significant capacity for
self-renewal, lamina propria macrophages of the gut are renewed continuously from the circu-
lating monocyte pool [13,14]. The proliferation and differentiation of the monocyte-macro-
phage lineage is controlled by the growth factor, macrophage colony-stimulating factor (CSF1),
which signals through a tyrosine kinase receptor, CSF1R [15–17]. The replenishment of the resi-
dent cells of the lamina propria requires the continuous exposure to CSF1 and lamina propria
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macrophages are rapidly depleted in mice treated with a blocking anti-CSF1R antibody [18,19].
Human macrophages are commonly generated by cultivation of isolated CD14+ monocytes for
4–5 days in CSF1 [20,21]. Several groups have published detailed transcriptomic analysis of the
differentiation of monocytes in CSF1 [20–23]. Based upon the known biology (derivation from
monocytes, dependence upon CSF1), we suggest that the monocyte-derived macrophage actu-
ally approximates an in vitro model of the differentiation of intestinal macrophages from
incoming monocytes.
Alongside CSF1, monocytes entering the lamina propria of the lower GI tract are immedi-
ately exposed to microbial products of which the archetype is lipopolysaccharide (LPS) from
gram-negative bacteria. Monocytes must rapidly down-modulate their response to bacteria in
the lumen, to avoid initiating an inflammatory response in the gut wall [18]. In response to
LPS, macrophages initiate a complex feed-forward and feed-back cascade of induction and
repression of transcription factors and autocrine regulators [24,25] leading to a new steady
state. The response of mouse macrophages to LPS has been studied in detail at many levels
from the mechanisms of signaling [26,27] through transcriptional networks [28–30] to the
underlying alterations in chromatin structure [31–33]. Dense time course data are required to
enable inference of the sequence of transcriptional events in this response.
The FANTOM consortium established tag sequencing of genome-scale 5’-RACE (CAGE) as
an expression profiling tool and used the approach to create a comprehensive human pro-
moter-based expression atlas [34]. Deep sequencing of CAGE libraries also detected the bidirec-
tional transcripts (eRNAs) derived from active enhancers enabling genome-wide quantification
of enhancer activity [35]. CAGE-based delineation of transcription start sites was used in the
comparison of the promoters of LPS-inducible genes in mouse and human macrophages [21]
as well as a recent detailed analyses of monocyte subsets [36]. Extensive analysis of cells under-
going state change showed a clear temporal pattern in induction of expression; enhancers are
expressed first, then transcription factor genes, and finally the genes they regulate [37].
In the current study, we analysed CAGE data generated within FANTOM5 to dissect the
transcriptional changes that occur in human macrophages grown in CSF1, and their subsequent
response to LPS, as a model for events that occur when monocytes adapt to the gut environment.
We use these data, combined with extensive data on the gene expression of blood monocytes
generated by the FANTOM5 consortium, to reassess the known candidate intervals associated
with IBD. Our analysis supports the hypothesis that IBD is primarily a macrophage-initiated
pathology and provides the basis for identification of alternative candidate genes within many
IBD susceptibility loci that have been identified by genome-wide analysis (GWA).
Results
Description of the datasets
The aim of this study was to examine the hypothesis that dysregulation of intestinal macrophage
responses to bacterial antigens is an important component of susceptibility to IBD. Initially, as
part of the FANTOM5 project, we produced a detailed quantitative analysis of promoter utiliza-
tion and gene expression across a dense time course of the LPS response of human monocyte-
derived macrophages (MDM) from three separate donors. The time course focused on very early
events (at 15 minute intervals from initiation of the response), as well as the later change in differ-
entiation state up to 48 hours after stimulation. For comparison, the FANTOM5 dataset contains
three additional unstimulated MDM samples from different donors, obtained commercially,
three separate CD14+ monocyte populations, each in triplicate, and cultured monocytes stimu-
lated for 2 hours with a range of agonists including gamma interferon (IFNγ) LPS and live salmo-
nella. The monocytes differed in their method of isolation. One set, also purchased commercially,
Macrophage transcriptional regulation and IBD susceptibility
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was clearly “activated” and expressed many inflammatory cytokines. Another set was divided
into the three known monocyte sub-populations based upon relative expression of CD14 and
CD16, as described in detail elsewhere [36,38]. The entire FANTOM5 dataset, including an
extensive mouse CAGE-based transcriptomic dataset is available on the ZENBU browser (see
below). All references in the text to the level of expression, or the temporal expression profiles of
individual genes within the text can be confirmed by accessing this browser and entering the
gene name.
Transcriptional landscape of the macrophage response to LPS
Previous studies of mouse macrophage response to LPS revealed sequential induction and
repression of numerous transcription factors [30]. To gain an overview of the transcription reg-
ulatory cascade of human macrophage response to LPS, we first utilized the data visualisation
tool Biolayout Express3D [39] to generate a pairwise correlation matrix based upon aggregated
expression of the promoter activity of annotated transcription factors identified previously [34].
The sample-to-sample graph in Fig 1, based solely upon the set of transcription factors, clearly
shows that the response to LPS can be visualized as a progressive and profound change in tran-
scription factor milieu. Gene-to-gene analysis showed that this involves at least 200 distinct
transcription factors. Fig 1 shows the averaged expression profiles of the transcription factor
genes within selected clusters, identified by the gene-to-gene analysis, emphasizing that the
transcription factor genes can be classified based upon the peak time of induction and whether
or not induction was sustained. The detailed list of the transcription factor genes within all of
the co-regulated clusters is provided in S1 Table. Many of these transcription factors are dis-
cussed below.
CAGE is essentially genome-scale 5’ RACE. Unlike microarrays, CAGE tag sequencing
resolves the separate and independent utilization of alternative promoters for the same gene,
and is significantly more sensitive across a large dynamic range [34]. For example, the CAGE
data reveal that SERPINA1 has at least 4 promoters. Macrophages and other myeloid cells pro-
files by the FANTOM5 consortium selectively utilize individual promoters p2, p3 and p4 of
the SERPINA1 gene, whereas p1 is liver-specific. Because it sequences only the 5’ ends, CAGE
does not require normalisation for the length of the transcript, which is necessary for RNA
sequencing (RNAseq) data, and is considerably more cost-effective than RNAseq. Extensive
validation of the CAGE methodology has been published elsewhere, showing the strong corre-
lation of CAGE tag peaks with tissue-specific chromatin marks and DNase hypersensitive
sites, and the precise colocation of the 5’ ends of the CAGE tags with the 5’ ends of full length
transcripts and promoter-associated motifs such as the TATA box [34–36]
We created a pairwise correlation network of individual promoters (defined as cluster of
transcription start sites, or CTSS) of all expressed genes (Fig 2). Because most genes have sev-
eral alternative promoters, the same gene can appear in multiple coexpression clusters. The
gene-to-gene (or more correctly, promoter-to-promoter) clusters, with graphical displays of
their average expression profiles can be accessed at http://coexpression.roslin.ed.ac.uk/lps, and
the gene names within selected clusters discussed in the text are also provided in S2 Table,
together with a summary of the pattern of expression. In keeping with the regulation of tran-
scription factors in Fig 1, the analysis revealed clusters of coexpressed promoters that have
peak activity at different times during the time course. The complex pattern is shown in a net-
work graph produced with the software Biolayout Express3D in S1 Fig. The network graph
groups sets of transcripts with related temporal profiles. The positions of clusters on the graph
progressively diverge from each other as sets of transcripts are induced or repressed compared
to the initial state. The clusters characterized by either early or late expression profiles are the
Macrophage transcriptional regulation and IBD susceptibility
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Fig 1. Transcription factor gene expression during stimulation of human monocyte derived macrophages
by LPS. A. Sample-based network of transcription factor gene expression. Gene-based expression levels for all of
the annotated transcription factors in the human genome [34] were extracted from the FANTOM5 data and averaged.
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most similar to the unstimulated state. So, the network graph forms a circle. The data are pre-
sented in more conventional heat map form in Fig 2. The heat map highlights the cascade of
transient regulation of gene expression with time in response to LPS, and the fact that no new
steady state is reached even after 48 hours. Within the first 15–30 minutes, there was a set of
genes that was rapidly induced and another set that was repressed. Thereafter, there were
waves of transient induction of thousands of promoters, each of which peaks at different time
points, ranging from 30–45 mins until 36–48 hours. In addition to those clusters that were
induced transiently, there were others that were induced in a sustained manner, so that at the
48 hour time point, the transcriptional state of the stimulated cells was still changing.
These coexpressed promoter clusters have been numbered in order based upon the number
of annotated genes they contain. The largest clusters, are slowly-repressed (Cluster 0) or slowly-
induced (Clusters 1, 2, 3, 4) peaking at different times late in the time course. Cluster 0 contains
many known cell cycle genes, and presumably reflects in part the cessation of cell division in a
subset of cells growing in CSF1. Clusters 1–4 are all enriched for innate immune genes.
Together, these slow-response clusters paint a picture of the progressive differentiation of the
cells, which parallels the progressive change in transcription factor milieu shown in Fig 1.
Induction of immediate early genes by LPS
Immediate early genes are a set of transcriptional regulators induced in many different cell
types as they transition from one cellular state to another. Cluster 5 (S1 Fig, Fig 2, S2 Table)
contains promoters with detectable increased expression within 15 mins, peaking at 45 mins,
and declining rapidly thereafter. This cluster of the earliest inducible promoters contains genes
encoding many immediate early transcription factors (EGR1, EGR2, EGR3, FOS, FOSB, JUN)
[37]. One of the most inducible, and the most highly-expressed, transcriptional regulators in
the LPS response is NFKBIZ, which encodes IκB-z. NFKBIZ has two promoters, both of which
were LPS-inducible. Induction of IκB-z is likely to be critical for subsequent events in the tran-
scriptional cascade [40]. In mouse macrophages, it interacts with AKIRIN2, to bridge NFκB
and the chromatin remodeling SWI/SNF complex on proinflammatory genes including IL6
and IL12B in macrophages [41]. The early-inducible transcription factors included genes
encoding factors more commonly associated with lymphocyte functions; NFIL3, IKZF1, KLF2
and PRDM1.
Two smaller clusters, 30 and 42 (S2 Table), were induced marginally later, peaking around
1hr 20 minutes. This group contained IFNB1, a target of NFκB signaling which is known to act
in an autocrine manner to induce the interferon target genes (see below). Other inducible
feed-forward activators include the gene encoding the adaptor protein TRAF1, which interacts
directly with signaling molecule MAP3K5 (also known as ASK1) which in turn is involved in
Only transcription factor genes where at least one value (averaged across three replicates) was 20 TPM were
included in the analysis. The results were entered into BioLayout Express3D to create a sample-to-sample network
layout where the nodes (spheres) represent a single time point after stimulation with LPS (averaged over three
replicates). Edges (lines between nodes) represent sample-to-sample correlations in overall expression pattern of
transcription factor genes of R 0.90. The time points are group and color-coded as indicated, showing the clear
progressive change in the transcriptional profile with time. B. Representative expression profiles for genes expressed
at the different time points. Clusters of co-regulated transcription factor genes were identified based upon gene-to-
gene network analysis with BioLayout Express3D (R 0.75; MCL inflation value 2.2) as described in Methods. The X
axis shows the time points (in the order 0 min, 15 min, 30 min, 45 min, 1 hour, 1 hour 20 min, 1 hour 40 min, 2 hours, 2
hours 30min, 3 hours, 3 hours 30 min, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours, 10 hours, 12 hours, 14 hours, 16
hours, 18 hours, 20 hours, 22 hours, 24 hours, 36 hours, 48 hours). Y axis shows the mean TPM value for the set of
genes with that profile (averaged across three replicates). Note that each cluster has a characteristic temporal profile.
The complete set of clusters and the names of the transcription factor genes within them is provided in S2 Table.
doi:10.1371/journal.pgen.1006641.g001
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LPS signaling [42] and the gene encoding EGR4, which along with EGR3, can interact with
NFκB and probably contribute to activation of NFκB target genes [43].
The inflammatory cytokine clusters
Genes for the well-known inflammatory cytokines (IL1B, TNF, IL6, IL10) and chemokines that
are the hallmark of the response to LPS form parts of Clusters 6 and 7 (S2 Table). A previously
unreported member of this group was TNFSF9, or CD137L, which was massively-induced by
LPS and has been proposed as a growth and differentiation factor for myeloid cells [44].
Expression of the proinflammatory genes differed from immediate early response genes in
terms of the duration of the expression. For example, TNF mRNA detected by CAGE was
induced 10-fold within 15 mins, but was still somewhat elevated after 5–6 hours. The small
MAF transcription factor gene, MAFF, was strongly induced alongside the inflammatory
Fig 2. Transcript expression in human macrophages exposed to LPS. Heatmaps of transcript expression in
human macrophages exposed to LPS depicting change from baseline, normalized to the maximum expression
of each transcript. Red = increase from baseline, green = decrease from baseline. Only nodes included in a
coexpression cluster are shown here. (A) All clustered transcripts in LPS-treated human monocyte-derived
macrophages. Clusters containing more than 50 transcripts are labeled. (B) Transcripts contained within the
clusters shown in (A) that initiate near a putative Crohn’s disease-associated SNP (p<10e-6, window size to
transcription start site = 2000 bases).
doi:10.1371/journal.pgen.1006641.g002
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cytokines. The other members of this family (MAFG, MAFK) were also induced by LPS, but
later in the time course. The small MAF transcription factors form heterodimers with many
other transcription factors, notably the NFE2 family (NFE2, NFE2L1, NFE2L2,NFE2L3 genes)
[45] all of which are induced by LPS later in the time course. Hence, induction of MAFF is
likely to be part of a feed forward cascade.
Interferon-response genes
Interferons (IFNs) and their targets are a key part of innate immune defence mechanisms, and
chronic over-expression of IFN target genes is a feature of many inflammatory diseases [46–
49]. The immediate early induction of IFNB1 in response to LPS initiates an autocrine loop
that leads in turn to downstream induction of the targets of IFN signaling [27,33,47,50]. Many
known IFN targets were induced by LPS and formed parts of coexpressed clusters, but distinct
clusters containing these genes followed distinct temporal profiles. Based upon a search of the
Interferome database [51], a total of 123 genes within Clusters 2 and 3 (the large late-response
clusters noted above) have previously been shown to respond directly to IFN signaling in
human monocytes or monocyte-derived macrophages. [51]. Several smaller clusters of known
IFN-response genes were induced significantly earlier. One, Cluster 10 (S2 Table), peaked at
2–3 hours, and included the IFIT2, 3 and 5 genes that derive from a single genomic region as
well as genes for known virus/IFN-induced chemokines, CCL3 and 4 and CXCL10 [52]. Other
clusters showing an early peak in expression contained genes for the known inducible feed-
back regulators of IFN-induced JAK-STAT signaling, SOCS1 and SOCS3 [53,54]. Cluster 11
peaked around 1 hour later than Cluster 10, and Cluster 17 peaked slightly later again, and
declined more slowly, similar to Clusters 33 and 49. [53,54].
The diversity of responses of IFN-inducible genes probably reflects the complex regulation
of the transcription factors that bind to interferon-response elements (IRFs). The canonical
MyD88-independent, TRIF/TRAM (TICAM1/2)-dependent pathway of IFN regulation deter-
mined from studies of mice involves the interactions of TRAF3 and the kinase TBK1 to phos-
phorylate IRF3 [55]. However, this pathway is not conserved in humans [21]. In the human
MDM, IRF3 mRNA was almost undetectable, and both TRAF3 and TBK1 were very low.
Genes encoding the adaptor molecule TICAM1, and the downstream RIK kinases (RIPK1,
RIPK2) were induced by LPS, peaking after 2–3 hours with Cluster 13.
The most-rapidly-induced IRF family member in the LPS-stimulated human MDM was
IRF1. This observation is consistent with recent direct evidence of LPS-induced IRF1 binding to
promoters and enhancers of inflammatory cytokine genes (TNF, IL6, IL12B) in human MDM,
and its role in the priming response to IFNγ [56]. IRF1 mRNA was induced detectably within
15 mins, peaked around 2 hours and was sustained at greatly elevated levels for the remainder
of the time course. IRF4 was part of cluster 17, maximally induced at 3–4 hours and declining
thereafter. IRF7 was induced marginally later and remained elevated throughout, IRF8 was
induced transiently, peaking at 3 hours and gone by 12 hours, IRF2 and IRF9 were induced in
late response clusters. Other components of the IFN signaling pathway, notably STAT1, STAT2
and STAT4, and JAK2 and JAK3 were also induced transiently. It is likely that each of these fac-
tors contributes specifically to transcription regulation of the clusters in which they are coex-
pressed possibly by interacting with other induced transcription factors. For example, IRF8 is
known to bind uniquely to a specific subset of IRF recognition sequences [29].
Inducible autocrine regulatory loops in the LPS response
Members of the FANTOM Consortium have produced a cellular interactome linking coex-
pressed ligands and receptors [57]. The progressive response of MDM to LPS emphasized in
Macrophage transcriptional regulation and IBD susceptibility
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Figs 1 and 2 and S1 and S2 Tables is based upon part upon numerous autocrine loops in which
induction of ligands is followed by induction of the receptors. The most obvious is the
response to endogenous IFNB1; the genes for receptors for type 1 interferon, IFNAR1 and
IFNAR2, were expressed in MDM and further induced starting around 5–6 hours. TNF has
also been shown to initiate an autocrine loop in mouse macrophages responding to LPS, so
that induction of some late response genes is ablated in TNF knockout mice [58]. Both TNF
receptor genes TNFR1 (TNFRSF1A) and TNFR2 (TNFRSF1B) were induced later in the
response to LPS. Aside from TNF, five other members of the TNF superfamily, TNFSF15,
TNFSF8 (encoding CD30L), TNFSF10 (TRAIL), TNFSF14 (LIGHT) and TNFSF9 (CD137L)
were each induced ahead of induction of their respective receptors TNFRSF6B,TNFRSF8,
TNFRSF10A and 10B and TNFRSF9 (CD137). The rapid induction of prostanoid synthesis is a
hallmark of LPS signaling, associated with the early induction of PTGS2 (COX2)[26]. PGE
receptors (PTGER3,4) and the prostacyclin receptor (PTGIR) were strongly induced at later
time points in the response. The gene for the vitamin D3-generating enzyme, CYP27B1, was
strongly-induced by LPS in MDM and the vitamin D3 receptor gene (VDR) was induced later
in the response to LPS.
Another set of potential autocrine loops was generated through the induction by LPS of
CSF1, GMCSF (CSF2) and GCSF (CSF3), commencing around 2–3 hours after LPS treatment.
Their receptors, CSF1R and CSF3R, were expressed constitutively and CSF2RB was strongly-
induced by LPS around 4–5 hours. The cytokine IL15 was induced substantially in MDM by 2
hours, whilst IL15RAwas induced from undetectable levels starting at 2–3 hours. Genes for
both IL27 subunits (IL27 and EBI3) were strongly induced, and MDM expressed IL27RA con-
stitutively. Finally, many of the inducible CC chemokines probably produce autocrine signals
through CC receptors; some were expressed constitutively, and some (e.g. CCR1,CCRL2,
CCR5,CCR7) were themselves LPS-inducible with distinct individual time courses.
Inducible feedback inhibition of the LPS response
One striking feature of the response to LPS is the transience of each successive wave of inducible
gene expression (S1 Fig, Fig 2). Each wave probably contains the seeds of its own destruction,
inducible repressors that promote decay of the signal and degradation of the induced transcripts
and proteins. For example, the set of induced autocrine loops elicited by LPS includes progres-
sive accumulation of the repressive cytokine IL10, alongside its receptor, IL10RB. The LPS time
course data supports many known and suggests several novel feedback loops. Amongst the ear-
liest inducible transcription factors in Cluster 5, PRDM1 (also known as BLIMP1) was the most
highly-expressed. In mice, the PRDM1 protein has been attributed functions as a transcriptional
repressor of cytokine induction [59]. IKZF1 (ikaros) has also been attributed roles in feedback
repression of LPS signaling in mice [60] and was associated with a trans-acting expression
quantitative trait locus (eQTL) in a large survey of gene expression in human peripheral blood
leukocytes [61]. NR4A1 (encoded by NR4A1) has also been implicated as a transcriptional
repressor of NFκB signaling in mouse macrophages [62]. Alongside these inducible feedback
repressors of transcription, Cluster 5 also contains promoters for feedback regulators of MAP
kinase signaling, DUSP1 and DUSP2 [63].
All of the inhibitors of NFκB (NFKBIA, NFKBIB, NFKBIE, NFKBIZ, BCL3)were rapidly
induced by LPS, as were genes for molecules such as TNFAIP3 (A20) which mediates feedback
inhibition of NFκB through regulated ubiquitination. OTUD1 encodes a novel inducible deu-
biquitinase (DUB) enzyme, in the same structural class as TNFAIP3 but not previously impli-
cated in control of the LPS response. Other induced genes for feedback repressors of the initial
signaling cascade include the protein tyrosine kinase LYN, multiple members of the TRIM
Macrophage transcriptional regulation and IBD susceptibility
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family of E3 ubiquitin ligases which promote degradation of signaling molecules (TRIM5,
TRIM10, TRIM25, TRIM35, TRIM36, TRIM38), the TRAF inhibitor TANK, multiple inhibi-
tor microRNAs (notably miR146A, miR155, miR21, miR3648, miR4741), IER3, each of the
GADD45 family members, which amongst many other targets, probably inhibit p38 MAP
kinases [64], the caspase inhibitor TNFAIP8 and the transcription factor ATF3 [28]. PPP1R
15A (also known as GADD34), a regulator of protein phosphatase 1 is identified as a feed-
back regulator of TLR-induced phosphorylation of TAK1 [65]. One gene of unknown func-
tion that was clearly induced was ZBTB10 (RINZF), most likely also encoding a transcript-
ional repressor [66].
Many proinflammatory genes encode short-lived mRNAs with AU-rich elements in their
3’UTR, subject to degradation by the ZFP36 (tristetraprolin) gene product [62,67]. Two related
genes, ZFP36L1 and ZFP36L2, have also been implicated in control of mRNA stability in LPS-
stimulated mouse macrophages [68]. However, by contrast to mouse macrophages, in human
MDM, ZFP36 is repressed by CSF1 (compared to high levels in monocytes), and none of the
ZFP36 family genes was highly-inducible by LPS. Instead, ZC3H12A, another gene encoding a
novel ribonuclease that controls stability of other inflammatory cytokine mRNAs, notably IL6
and IL12p40 [69], was highly-induced by LPS, within a similar time course to TNF, but remained
elevated even after 48 hours. Interestingly, PARP14, encoding a member of a family of intracellu-
lar proteins that generate ADP-ribose posttranslational adducts, was strongly induced by LPS,
commencing around 2 hours, and peaking at 12 hours (within Cluster 3). PARP14 forms a com-
plex with ZFP36 and the AU-rich element in the mRNA 3’ untranslated region of the tissue fac-
tor (TF) gene [70]. The neighbouring PARP15 and PARP9 genes were also induced by LPS.
PARP9 shares a shares bidirectional promoter with the E3 ubiquitin ligase gene DTX3L, and the
two proteins interact to control, amongst other things, the function and expression of IRF1 [71].
Other members of the PARP family, PARP7, PARP10 and PARP12, which control protein trans-
lation [72] and/or feedback inhibit NFκB signaling [73] were also LPS-inducible at later time
points. Based upon the function in mice, the inducible expression of the signaling molecule
gene, IRAK2 [74] and the regulator of intracellular trafficking, optineurin [75] probably contrib-
utes positively to the sustained induction of inflammatory genes.
HCAR2 and HCAR3 (also known as GPR109A and GPR109B) are neighbouring duplicated
genes in the human genome, and encode receptors for butyrate and niacin. Both genes were
induced in parallel by LPS. In mice, GPR109A has been associated with feedback regulation
of the LPS response and suppression of macrophage reactivity to gut luminal contents [76].
PELI1 (Pellino1) encodes an E3 ubiquitin ligase that is required for TRIF-dependent signaling
from TLR3 and TLR4 [77] and probably enables subsequent induction of the IFN target genes.
XBP1 lies downstream of the gene for the ER stress sensor kinase, IRE1alpha (ERN1), and in
mice XBP1 was found to be required for optimal and sustained cytokine production by macro-
phages responding to LPS [78]. The gene for another target of ER stress, PPP1R15B [79] was
induced in parallel with XBP1. MSC, encoding musculin or activated B cell factor-1 (ABF-1)
[80], a repressor of bHLH transcription factors in muscle and B cells which has not previously
been reported in macrophages, was also within this cluster.
One novel finding was the marked induction of PDSS2. PDSS2 encodes prenyl (decaprenyl)
diphosphate synthase, subunit 1, an enzyme involved in the synthesis of coenzymeQ (CoQ). It
is not known whether the activity of this enzyme limits flux through the pathway, but heterozy-
gous mutation in another gene in the CoQ pathway, Mclk1 (Cog7) in mice, produced increased
levels of TNF in macrophages, and hypersensitivity to LPS [81]. Hence, this gene probably also
contributes to feedback inhibition of the LPS response.
The autocrine interferon response induces its own set of feedback regulators, notably the
obvious suppressors of cytokine signaling (SOCS1, SOCS3 and SOCS6) which were each
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induced with distinct time courses (S2 Table). PLEKHF2 is linked to control of interferon pro-
duction [82]. LPS-inducible GPR183 (also known as EBI2, or EB virus induced 2) is a feedback
regulator of type 1 interferon pathways [83]. The ligand for EBI2 is 7α,25-dihydrocholesterol
and the enzyme that synthesises it, CYP7B1, was also induced strongly by LPS.
Finally, the induction of the metal ion responsive transcription factor, MT1, is linked to the
recently described role of zinc in feedback regulation of NFκB activation and inflammatory
transcription [84]. Indeed, genes for the zinc transporters, SLC39A8 (ZIP8), SLC39A14
(ZIP14) and SLC30A1 (ZNC1), were each strongly induced by LPS, commencing from around
4–5 hours after induction, and rising continuously.
The activation of enhancer-associated transcription in response to LPS
precedes target gene activation
LPS stimulation of mouse macrophages was reported to induce transcription from some 3000
enhancer loci, preceding modification of histone methylation [31,85]. eRNAs are relatively
unstable, and are degraded by the RNA-exosome complex [86]. However, CAGE enables their
quantitative detection, and the activation of eRNA transcription can be correlated with subse-
quent activation of promoter activity in putative target genes in the chromosomal vicinity [35].
Many enhancers described by the FANTOM5 consortium came from stimulated monocytes.
The genes encoding limiting exosome components, EXOSC3 and EXOSC10 were low in MDM,
and repressed transiently between 1 and 2 hours after LPS stimulation. CAGE tags derived from
the genes encoding several other exosome components, EXOSC1, EXOSC2, EXOSC5 and
EXOSC7, were almost undetectable in monocytes in culture. The relative lack of the exosome
complex may facilitate the detection of active enhancers in monocytes and macrophages.
S2 Fig shows profiles of enhancer activation at a selected subset of inducible genes in which
there was robust activation of transcription that clearly preceded the appearance of transcripts
from associated promoters. In every case, the enhancers that have been identified in the time
series are robustly supported by evidence of inducible bi-directional transcription in the LPS-
stimulated monocytes. The data strongly support the view that enhancer transcription pre-
cedes activation of target promoters [35].
In many of these cases there were numerous individual regulated enhancers apparently
associated with a single inducible promoter. For example, the IL6 locus has recently been dis-
sected in detail in human monocyte-derived macrophages responding to LPS [56], showing
the roles of STAT1 and IRF1 in establishing permissive chromatin architecture in the vicinity
of the gene, and identifying sites up to 50kb upstream of the transcription start site. The FAN-
TOM5 data for the LPS induction series revealed LPS-inducible bidirectional transcription up
to 150 kb upstream of IL6. Fig 3 shows a time course of detection of transcription of each of
these elements; nine separate elements had detectable activity in LPS-stimulated MDM in
advance of the peak of IL6 promoter activity. These elements were more readily detectable in
LPS-stimulated monocytes, where almost all of the 25 detected enhancers had significant tran-
scriptional activity.
The chemokine genes CCL3 and CCL4 are coregulated by LPS. Here again, there was bidi-
rectional promoter activity associated with enhancers outside, and between, the two inducible
genes, more readily detected in the LPS-stimulated human monocytes (Fig 4). Two enhancers
downstream of CCL4 (to the right of the panel) were induced ahead of coordinated induction
of CCL3 and CCL4 promoter activity. By contrast, the neighbouring CCL18 gene was much
more slowly induced, and four enhancers appeared to show more prolonged activation. The
entire region shows evidence of bidirectional promoter activity in LPS-stimulated monocytes.
Finally, the region surrounding the TNFAIP3 locus contained an array of enhancers extending
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over 400kb, at least 25 of which had detectable induction of transcription in advance of the
activation of the promoter (Fig 5).
A recent study identified around 120 long non-coding RNA (lncRNA) that were
induced by LPS in human monocytes based upon RNAseq [87]. We reexamined these
loci individually in the FANTOM5 data. All but one of the top 20 most-inducible candi-
date lncRNA were contained within large clusters of enhancers (so-called super-enhanc-
ers) identified by the FANTOM5 data, and were actually associated with bidirectional
transcription in LPS-stimulated monocytes. The potential target loci identified included
IL6 and TNFAIP3 (discussed above), as well as IDO1, miR155, ACSL1, IRF2, HS3ST3B1,
TNFSF8, DDX58, CD38 and SLAMF7. The only exception is NONCO3094, which is driven
by a strongly-LPS-induced promoter that is antisense to IL7 (which is not itself expressed
in monocytes/macrophages). Based upon the extensive linked CTSS associated with
enhancers in these regions, there is some question as to whether the proposed lncRNA
could actually be artificially concatenated over-lapping short RNAs.
Fig 3. The time course of activation of enhancers and promoter at the IL6 locus. The core panel shows a genome browser view of the IL6 locus
with the locations of FANTOM5 enhancers. The upper right panel shows the time course of induction of IL6 mRNA, detected by CAGE, which peaks
around 3–4 hours and declines by 12 hours. The lower panels show the transient activity of the enhancers indicated, the majority of which peak around
1–2 hours and decline rapidly. Data are expressed at TPM, and are the average of the three replicates.
doi:10.1371/journal.pgen.1006641.g003
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Global analysis of the transcriptional cascade from motif activity
response analysis
When sets of co-regulated genes share a particular motif in their promoters, we can infer that
DNA binding protein(s) that recognize the motif regulate that set of genes. We utilized Motif
Activity Response Analysis (MARA) [88] to identify transcription factor binding motifs associ-
ated with the response of the MDM to LPS. Fig 6 shows the motif activities for the most active
motifs. There was a temporal separation of motif activities associated with enhancers (red lines
in Fig 6), which peaked before the activation of promoters through the same motifs (blue lines
in Fig 6). The exception to this pattern was the macrophage-specific transcription factor, SPI1
(PU.1), which showed early motif activity for enhancers, but no subsequent activation on
Fig 4. The time course of activation of enhancers and promoters at the CCL3/CLL4/CCL18 locus. The core panel shows a genome browser view of
the locus with the locations of FANTOM5 enhancers. The upper panel show the time course of induction of each of the mRNAs, detected by CAGE. Whereas
CCL3 and CCL4 are coordinately-regulated, CCL18 follows a much slower time course and is still rising at 48 hours. The lower panels show the activity of the
enhancers indicated. The lowest track shows the histograms of CAGE tags mapped to the region, with colours indicating direction of transcription; green to
the right and purple to the left. Note that the entire regions shows evidence of bidirectional transcription initiation. Data are expressed as TPM, and are the
average of the three replicates.
doi:10.1371/journal.pgen.1006641.g004
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Fig 5. The time course of activation of enhancers and promoter at the TNFAIP3 locus. The core panel shows a genome browser view of the TNFAIP3
locus with the locations of FANTOM5 enhancers. The lower right panel (p1@TNFAIP3) shows the time course of induction of TNFAIP3 mRNA, detected by
CAGE, which peaks around 2 hours and declines to a new, elevated steady state by 8 hours. Other panels show the transient activity of the enhancers
indicated, the majority of which peak around 1–2 hours and decline rapidly. Panel at bottom right shows the activity of the enhancer containing the SNP
originally associated with CD susceptibility, 185kb upstream of the TNFAIP3 locus [2]. Data are expressed as TPM, and are the average of the three
replicates.
doi:10.1371/journal.pgen.1006641.g005
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Fig 6. Motif activity response analysis (MARA) of the response to LPS MARA analysis of promoters and
enhancers was carried out as described in Materials and Methods. MARA averages the expression of all
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promoters. This finding is consistent with the proposed role for PU.1 as a pioneer transcrip-
tion factor that defines “latent enhancers” that are subsequently bound by other factors in
response to agents such as LPS [32,89].
The earliest response detected by MARA was associated with the Fos/Jun, or AP1 motif,
consistent also with these factors being amongst the earliest targets of LPS activation (see
above). Subsequently, the increased activity of the NFKB/REL/RELA motif peaked around 2
hours, but declined only slowly (Fig 6). An initial burst of activity probably derives from the
translocation of a preexisting complex subsequent to activation by IKB kinases [27]. Subse-
quently, from around 2 hours, genes encoding all of the members of the NFκB family, REL (c-
rel), RELA (p65), RELB, NFKB1 and NFKB2, were induced and presumably contributed to
both replacement of the cytoplasmic pool of NFκB and transcriptional regulation of a distinct
late-response set of target promoters containing the NFKB/REL/RELA motif. The progressive
increase in motif activity of IRF1/2, IRF7 and STAT2,4,6 was initiated later in the time course,
and is entirely consistent with the induction of IFNB1, and of the IRFs themselves, as discussed
above.
The MARA analysis reinforces the likely importance of the stress response in LPS action.
NFE2 (also known as NRF) sites were previously identified as active motifs in LPS-stimulated
mouse macrophages [30]. The stress response factors, NFE2L1 (NRF1) and NFE2L2 (NRF2)
are the likely occupiers of the NRF sites, being expressed constitutively in MDM but further
inducible by LPS. The motif annotated as NFATC (1. . .3) is most likely bound by NFATC1,
which was induced by LPS, peaking at 2 hours. NFATC1 has two promoters encoding alterna-
tive 5’ exons in both mouse and human, as discussed in a recent review [90]. The more distal
promoter was stimulated by LPS. NFATC1 is itself a downstream target of both AP1 and NFκB
factors [90].
MARA also implies a function for the MEF2 family. MEF2A, MEF2C and MEF2D, which
recognise the MEF2 motif, were all expressed constitutively in MDM, as described by others
[91] and the latter two were down-regulated by LPS late in the time course. Like NFκB these
proteins undergo regulated nuclear translocation [92]. MEF2 most likely underlies the motif
activity attributed to the serum response factor SRF (another MADS box protein). Although
there have been reports of the activity of SRF in mouse macrophages [93] SRF was expressed at
barely-detectable levels in MDM, similar to the Ets components of the serum-response ele-
ment complex (ELK1, ELK3, ELK4).
The absence of detectable motif activity based upon MARA does not constitute evidence
that any particular factor does not contribute to transcriptional regulation. The GGAA/T core
motif bound by ETS family factors is relatively uninformative, and overlaps with the purine-
rich PU.1 motif found in many myeloid-specific promoters [16]. Genes encoding ETS factors
with related binding motifs, including ETS2, ELF4, FLI1, ETV3, ETV5 and ETV7 (TEL) were
each up-regulated by LPS with distinct kinetics. Sweet et al. reported previously that ETS2 is
not only induced, but is phosphorylated on the pointed domain, required for effective trans-
activation, in response to LPS [94].
MARA is also rather insensitive for the detection of activity of factors that bind GC-rich
motifs within CpG island promoters. For example, the “KLF4” motif (CaCaCCC) showed little
change in activity across the LPS time course. However, as evident from the clusters in Fig 1,
multiple members of the KLF family were regulated in response to LPS. KLF2 was one of the
promoters (blue) and enhancers (red) that contain the consensus transcription factor binding motif. Activities are
plotted as Z-scores (averages of activity divided by standard deviation) in each time point, with error bars
representing the standard deviation of Z-scores.
doi:10.1371/journal.pgen.1006641.g006
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immediate early genes. KLF7 has two promoters, one induced by 2 hours, another induced
later in the time course. KLF5 was induced even later (around 3–4 hours, cluster 43). KLF3
also has two promoters, one induced at 7–8 hours, one at 20 hours. Each of these KLF family
members could have a distinct function and distinct target genes. In mice, KLF4 was suggested
to be a feedback regulator, and to polarise macrophages towards M2 phenotype [95]. In
humans, KLF4 was constitutively expressed in monocytes and almost completely repressed in
MDM. It was transiently, but relatively weakly-induced by LPS. KLF6 did not cluster in the
coexpression analysis, having an idiosyncratic expression pattern. It was induced rapidly,
peaking by around 80 mins in all samples, but unlike most early response genes, it declined
slowly and remained somewhat elevated even after 48 hours. KLF6 is in a rather gene poor-
region of the genome, and is surrounded by numerous enhancers identified in the FANTOM5
dataset. Of these, at least 4 were detectably and transiently-induced ahead of the peak of accu-
mulation of KLF6. KLF6 is required for optimal LPS-induced gene expression in mice [96].
Macrophage-specific gene expression and inflammatory bowel disease
susceptibility
Based on the observations described above, we hypothesised that IBD-associated genes, of
which NOD2 is an archetype, are likely to be specifically-inducible in monocytes in response
to inflammatory stimuli AND down-regulated during differentiation to macrophages. In
order to test this hypothesis, we quantified the evidence for disease association in the regions
surrounding promoters meeting these criteria. 2413 promoters exhibited this expression pat-
tern, out of a total of 201,801 promoters in the FANTOM5 dataset. After correcting for linkage
disequilibrium, regional co-regulation, and the genomic distribution of variants (see Meth-
ods), we found that variants associated with Crohn’s disease by GWA were very strongly
enriched in the regions surrounding this set of promoters (Fig 7). Less enrichment was seen
for genes putatively associated with ulcerative colitis, and no significant enrichment was
observed for control sets of loci/SNPs associated by GWA with the other traits (rheumatoid
arthritis (RA), LDL cholesterol, and height). The association between CD loci and regulated
transcription in macrophages can also be visualized by examining the expression profiles of
promoters that lie within 2kb of a putative Crohn’s disease-associated SNP (p<10e-6). This
subset is displayed in Fig 2B.
To enable visualization of the results of the CAGE data with the location of disease-associ-
ated SNPs, we created a genome viewer that displays locations of FANTOM5 promoters and
enhancers together with the P values for association with CD and UC and other traits (http://
gsht.baillielab.net; available for review; this resource is currently being transferred to a perma-
nent server, which will be available at the time of publication. We also provide a direct link to
visualize the association data on the ZENBU browser (see Methods).
The most extensive meta-analysis of IBD GWA data to date [4] identified 163 loci that met
genome-wide significance thresholds for CD, UC or IBD. A subsequent study identified an
additional 38 loci that underlie shared genetic risk across different ethnicities [5]. Most dissec-
tions of candidate genes in GWAS focus on the nearest gene to the peak of association, or the
genes within the genomic interval of association, and assume that actual causal variants are in
high LD with the SNP(s). The genomic intervals are not always precise, and of course they
may contain enhancers that alter transcription of genes outside that interval.
The criteria we tested (specifically inducible in monocytes; down-regulated during differen-
tiation to macrophages) identify plausible alternative candidates in many known IBD loci. For
example, the MUC19 gene on Chr12 is annotated by Jostins et al. [4] as the only gene with the
IBD GWA candidate interval defined by SNP rs11564258. However, Lacour et al. [97]
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Fig 7. Enrichment of macrophage-expressed or regulated genes in genomic regions associated with
IBD susceptibility Each panel shows the enrichment of GWAS-associated variants in vicinity of genes
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identified an extended haplotype that includes the neighbouring LRRK2 gene, a clear candidate
for which there is already functional evidence of a role in IBD [98]. LRRK2 is identified by our
criteria, and shares transcriptional regulation with NOD2, being expression and further
induced by IFNγ in monocytes and ablated by CSF1 in monocyte-derived macrophages.
S3 Table provides a detailed manual curation of genes within >200 genomic intervals from
published IBD datasets, inspected using the viewer described above, and gene expression
derived from the FANTOM5 data. All but 12 of the intervals within the boundaries of signifi-
cant GWA peaks for IBD contained promoters/genes for which expression was strongly
monocyte-macrophage-enriched and/or regulated by CSF1, LPS or both. For some regions
identified by GWA, no candidate gene had been proposed but the CAGE data implicate a
novel candidate that was expressed and/or regulated specifically in monocytes or macrophages
or both. For others, our analysis identified alternative candidates to those that are currently
emphasized. For example, NOD2 was regulated in parallel with two flanking genes, SNX20 and
CYLD (cylindromatosis). These three genes are close to monocyte-specific, IFNγ -inducible
enhancers, detected by CAGE, located in the interval between NOD2 and SNX20. All three
genes were expressed highly in monocytes and almost absent from MDM grown in CSF1.
SNX20 has been implicated in control of P-selectin location, and might therefore also contrib-
ute to extravasation of monocytes [99]. CYLD encodes a deubiquitinating enzyme that exerts
feedback control on both NFκB and MAP kinase pathways and has itself been implicated in
inflammation control [100]. So, even in this archetypal CD susceptibility locus, NOD2, the
gene that has been most studied, is not necessarily the best or only candidate, notwithstanding
evidence of protein-coding variation.
Another well-studied candidate IBD susceptibility gene, ATG16L1, was expressed ubiqui-
tously in the FANTOM5 atlas, providing no support for a gut-specific or inflammatory pathol-
ogy. By contrast, the neighbouring gene, INPPP5D (inositol polyphosphate 5-phosphatase,
also known as SHIP1), shares tight co-regulation with NOD2, being high in monocytes,
induced by IFNγ, down-regulated in MDM, and further ablated by LPS. Mice deficient in
SHIP1 have chronic inflammatory disease, including a Crohn’s-like colitis [101]. A recent
detailed analysis of the ATG16L1 association with IBD revealed that the commonly-studied
SNP is in linkage disequibilibrium with SNPs across an extended haplotype and additional var-
iants could implicate any region of the locus [102]. The CAGE data also identified at least four
monocyte-specific, regulated enhancers in the 40kb interval between ATG16L1 and INPPP5D,
including one only 2.5 kb upstream of the ATG16L1 locus (Chr2:234156397). Immediately
downstream of ATG16L1, another candidate within the genomic interval identified by linage
to CD is DGKD, diacylglycerol kinase delta, also expressed highly in monocytes and ablated
completely in MDM. The hypothetical involvement of dysregulated autophagy in IBD [4], is
based largely on association with ATG16L1 and is cast into doubt if this gene is not the only, or
even the most likely, candidate gene in the region.
The association of IBD susceptibility with autophagy also rests in part upon genetic linkage
to IRGM, which has been linked in turn to the functions of the large family of inducible
GTPases in the mouse. The original study of human IRGM [103] refers to the gene as an ortho-
log of mouse Irgm1, but the location of human IRGM in the genome is actually not syntenic
meeting the expression criteria (specifically inducible in monocytes AND down regulated during differentiation
to macrophages) for each of the traits/diseases shown. For 1000 bins spanning a region of 1Mb above and
below all TSS meeting expression criteria, observed:expected ratios were calculated as the ratio of the
absolute count of variants with p<1e06 for association with each trait, to the absolute count of all SNPs
genotyped in the same study. p-values for enrichment were calculated for the whole set using PASCAL (see
Methods).
doi:10.1371/journal.pgen.1006641.g007
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with mouse (http://www.ensembl.org). Humans have lost the inducible GTPase family as a
mechanism of host defense, and IRGM was shown not to be interferon-inducible in humans
[104]. The evidence that the human IRGM locus actually encodes an expressed transcript or a
functional protein that is detected in any cell type is equivocal [105]. Strongly indicating that it
does not, the FANTOM5 CAGE data detects no expression of IRGM mRNA in any cell popu-
lation or tissue in any state of activation. The IRGM SNP associated with IBD susceptibility is
in strict LD with a 20kb deletion polymorphism, 2.5kb upstream of the putative TSS of IRGM
[106]. One alternative explanation for the association is that the IRGM region contains distal
enhancers for macrophage-expressed genes. Chromatin immunoprecipitation sequencing
(ChIPseq) data derived from monocytes and macrophages suggests this is the case, with clear
peaks for binding of PU.1 and enhancer marks [20] corresponding to a cluster of enhancers
identified by CAGE, which can be visualised on the ZENBU browser. Amongst the neighbour-
ing genes, SMIM3, encodes a small integral membrane protein about which little is known, but
it is up-regulated in MDM and further induced by LPS. The most likely candidate is TNIP1,
encoding a regulator of NFKB signalling, which has been implicated in genetic susceptibility
to other inflammatory diseases [107].
The association of the NKX2.3 locus on chromosome 10 with IBD susceptibility has been
widely-reported and replicated, but no function of the gene product associated with inflamma-
tion has been described. Within the same region, SLC25A28 encodes a mitochondrial iron
transporter (also known as mitoferrin 2) which showed the same pattern of regulation as
NOD2, down-regulated in MDM compared to monocytes, but very strongly-induced by LPS.
Similarly, no mechanistic link has been made between the SNP associated with the IL23R locus
and IBD susceptibility, but there has been considerable emphasis in the literature on the cen-
tral role of Th17 T cells, activated by IL23, in disease pathogenesis [4]. There is an alternative
myeloid-expressed candidate gene, MIER, within the linked candidate interval surrounding
IL23R.
Previous data have revealed that promoters and enhancers identified by CAGE are strongly
enriched for informative SNPs in GWAS [35]. One specific example is the IL12B locus, where
the SNP rs6871626, associated with CD susceptibility, is located within one of a cluster of LPS-
inducible upstream enhancers. Interestingly, susceptibility to tuberculosis in an African cohort
has been associated with a separate SNP cluster 3’ of the IL12B locus and of the neighbouring
UBLCP1 gene ([108]). The UBLCP1 gene is expressed ubiquitously, but these remote enhanc-
ers were activated by LPS in both monocytes and MDM. Similarly, Jiang et al [109] identified
multiple allelic variants in the PTGER4 locus on chromosome 5, that associated independently
with CD. The FANTOM5 data revealed around 50 LPS-inducible enhancers in the 0.5Mb
upstream of PTGER4. Confirming this pattern, the subset of CTSS within 2kb of a putative
CD-associated promoter has a distinct pattern in the LPS time course data.
Prior to the adoption of population GWAS, family-based studies identified six IBD loci
with very high relative risks amongst related individuals. IBD1 contained NOD2, and IBD3,
the well-known association with the complex HLA locus. IBD5, located around chromosome
5q31, was located to a missense mutation in the organic cation transporter, SLC22A4 [110]
and a promoter variant in the neighbouring SLC22A5 gene. The combined haplotype con-
ferred a 7.5 fold risk of Crohn’s disease [111]. Consistent with our hypothesis, SLC22A4 was
highly-expressed in CD14+ monocytes, and completely down-regulated by CSF1. The IBD6
locus was located on Chromosome 19p13, by analysis of patients/families that did not possess
NOD2 variants [112]. Subsequent analysis revealed multiple variants associated with the linked
EMR1, EMR2, EMR3 and CD97 cluster of genes that contributed to the overall IBD susceptibil-
ity. All four of these genes were expressed at high levels in monocytes, and strongly down-reg-
ulated by CSF1. The strong expression of EMR1 contradicts previous report claimed that
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human EMR1 is expressed only in eosinophils [113]. Emr1 in mice encodes the F4/80 antigen,
widely used as a macrophage marker [113]. The expression of EMR1 in humans is clearly dif-
ferent in mice, where the mRNA and protein are actually induced by CSF1 and are retained on
tissue macrophages. However the phenotype of a knockout of the gene in mice implies a func-
tion in oral and peripheral tolerance [114].
To further explore candidate loci, we considered one individual component of the criteria
described above that is central to our hypothesis: the large set of promoters that is expressed
in freshly-isolated blood monocytes (excluding those that were isolated by adherence and
culture in vitro) and either up or down-regulated at least 5-fold in monocyte-derived macro-
phages grown in CSF1. These promoters and their expression values in all samples analysed
are shown in S4 Table; in many cases we identified multiple promoters from the same locus,
as well as distal enhancers that have not been ascribed the gene name, but may be connected
based upon their apparent strict coexpression [35]. Excluding existing candidate genes such as
NOD2/SNX20, amongst the promoters down-regulated by CSF1 in MDM, and associated
with specific gene names, at least 88 genes were identified as functional candidates lying within
200kb intervals with a peak p value of at least 10−6. These are annotated in S4 Table. Amongst
these new candidates, several transcription factors (JUN, FOS, FOSL2, JUND, ETS1, ETS2,
NFKB1, NFKBIZ, NFKBIA, CREM, SMAD3, BATF3, NFAT5, NR1D1, RARA,NFACTC4,
FOXP1, PRDM1, NFIL3, KLF3) are of particular interest since they are likely to produce trans-
acting impacts. Note that CSF1 strongly down-regulates many of the non-MHC genes within
the HLA region on chromosome 6 (and to a lesser extent, most Class II MHC (HLA-D) tran-
scripts) providing an alternative explanation for some of the well-documented HLA associa-
tion with CD. Amongst the CSF1-inducible genes annotated in S4 Table there were a further
46 candidates. This set did not include any transcription factors, and in the large majority of
cases, the association was specific to either CD or UC. In passing, we noted that the CSF1-in-
ducible set separately identifies many genes, including CSF1 itself, with loci associated with
lipid traits (e.g. LDL cholesterol), and as previously noted [115], CSF1 induced many genes
associated with lipid metabolism. The IBD loci identified by Jostins et al. [4] do not include
any on the X chromosome, which is consistently under-represented in GWAS [116]. Never-
theless, there is evidence for X-linked IBD susceptibility [117]. Amongst the genes on the X
chromosome, TLR8 is strongly monocyte-specific, and is part of an extended haplotype associ-
ated with IBD [118]. ARHGEF6, also linked to CD [116], is also strongly monocyte-enriched
and expression was abolished in MDM.
In summary, on the sole basis of regulation in monocytes by CSF1 as a biological prior, we
identify a further 134 candidate genes associated with IBD susceptibility, in addition to novel
candidates within IBD loci identified from traditional linkage analysis. S4 Table contains
many additional regions that are not associated with a gene name, and the larger set of 2400
promoters analysed in Fig 7 (S5 Table) contains 392 named genes that will undoubtedly
expand the list of candidate functional loci still further.
Discussion
The monocyte-derived macrophage response to LPS as a model for
intestinal macrophage differentiation
We analysed the response of human macrophages, differentiated in CSF1, to the TLR4 agonist
LPS in order to determine whether this mirrors the development of gut macrophages and
hence whether gut macrophages might be involved in the development of IBD. The direct rele-
vance of this system to IBD is reinforced by the recent identification of a functional missense
variant in the LPS receptor, TLR4, associated with Crohn’s disease [2].
Macrophage transcriptional regulation and IBD susceptibility
PLOS Genetics | DOI:10.1371/journal.pgen.1006641 March 6, 2017 21 / 36
We have produced an unprecedented analysis of the transcriptional events during the
response of macrophages to LPS. Figs 1 and 2 and S1 Fig overview the complex transcriptional
cascade of feed-forward and feedback regulation of sets of genes so that the transcriptome is
not stable even after 48 hours. The earliest events detected were the induced transcription of
enhancers ([37] (S2 Fig). As a class these regions are opened by binding of pioneer transcrip-
tion factors. In the case of macrophages, the dominant pioneer is PU.1 [20,89,119,120]. The
observation that enhancer transcription precedes activation of target promoters is known
from other systems, and indeed one might use this correlation to infer the likely connection
between distal enhancers and promoters [35]. What is less obvious in all of the examples
shown in Figs 3, 4, 5 and S2, is that the induction of enhancer activity appears transient, even
when the putative target gene is induced relatively stably. The transcripts are presumably rap-
idly degraded by the exosome complex. This suggests that the act of transcription of an
enhancer is associated with its activation, but the transcript per se is less likely to be functional.
Subsequent to early enhancer activation, wave after wave of transcription factors was
induced (Fig 1) followed by their putative target genes (Fig 2) which were identified by enrich-
ment of target motifs in their promoters (Fig 6). Genes for the inducible transcription factors,
such as the members of the IRF family, formed clusters with their likely target genes, which
contained binding site motifs detected by MARA. The temporal data provide indications of
distinct and specific roles. For example, distinct members of IRF family were found in different
clusters whereas in a previous analysis of monocyte eQTL data, IRF7 and IRF9 clustered
together [47].
The endpoint of differentiation of mucosa-associated macrophages is a population that is
longer responsive to restimulation with LPS or other microbial challenges [121]. The FAN-
TOM5 data demonstrate that MDM grown in CSF1, in common with mucosal macrophages,
strongly down-regulated most pathogen recognition molecules expressed at high levels in
monocytes, notably TLR1, 2, 4 and 6, NOD2 and other Nod-like receptors (NLR) and non-
NLR inflammasome activators (NLRC3, NLRC5, NLRP1, NLRP3, NRLP6, MEFV, PYCARD),
C-type lectins CLEC7A (dectin1), CLEC5A,CLEC4D,CLEC4E and CLEC12B; SIGLECs 3, 5, 9,
10 and 14, formyl peptide receptors FPR1 and FPR2, recently described cytoplasmic LPS recep-
tors CASP4 and CASP5 [36] and the nucleic acid detector CGAS. There is clearly the potential
for dysregulation of any of these individual pattern recognition receptors, which could explain
why it has been difficult to link IBD incidence to particular microbial challenges common to
all patients [1,122].
Compared to monocytes, MDM also shared with human gut macrophages the suppres-
sion of CD14 (the LPS coreceptor), and adaptor and signaling molecules such as MYD88,
TRIF, TRAF6 and IRAK1. So, although they clearly do respond to LPS, the response of
MDM is greatly attenuated compared to the response of blood monocytes. The FANTOM5
data assays the blood monocyte response to LPS at only a single time point, but based upon
the quantitative measure of CAGE tag frequency, the classical inflammatory cytokines, IL1B
and IL6 were each induced by LPS to levels 10–100 fold greater in monocytes than at any
time point in the MDM time course. By contrast, the monocyte attractants, CCL2, CCL3
and CCL4 were induced to comparable levels in MDM and monocytes. We suggest that
once inflammation has been initiated through the activation of hyper-responsive incoming
monocytes, or resident macrophages, accelerated recruitment of further monocytes would
induce a self-perpetuating hyperinflammatory state. TGFB1 has also been implicated in
mucosal macrophage differentiation, and strongly implicated in IBD [123]. The modulated
response of MDM to LPS probably involves this factor. The MDM are most likely autocrine
for TGFB1 signaling, since they express high levels of TGFB1 mRNA, and both receptors,
TGFBR1 and TGFBR2.
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Extensive feedback control of the LPS response
The rigorous feedback control that is documented here has previously been seen as a way to
produce robustness and stringent control [24]. If this were true, one might expect the system
to be resilient in the face of varied expression or function of individual components. This is
clearly not the case. Most of the literature on the function of inducible repressors derives from
studies of inbred mice, in which knockout of any one these regulators produces dysregulated
LPS responses [24,25,83]. Parnas et al. [124] reported a genome-wide CRISPR screen that
revealed hundreds of genes apparently required for the production of TNF by mouse macro-
phages in response to LPS. The structure of the screen did not reveal as many genes involved
in negative regulation. To gain further insight into the scale of feedback control of the
response, we searched PubMed to identify mouse knockouts that impact the response to LPS.
S6 Table identifies >180 additional mouse loci where a null mutation is viable but produces a
global change in macrophage responsiveness to LPS in vitro and/or in vivo. The list does not
include all of the inflammatory cytokines and chemokines, and essential signaling molecules.
Almost 2/3 of these mutations produced hypersensitivity to LPS administration or sepsis in
vivo, and many also produced spontaneous colitis. The set of LPS susceptibility genes in S6
Table is annotated with the expression from the FANTOM5 data, and excludes the obvious
signaling molecules and inflammatory cytokines and chemokines in the KEGG Toll-like
receptor signaling pathway (hsa04620). In every case, the FANTOM5 data confirms that the
genes are also expressed/enriched in human monocytes and/or regulated by CSF1, LPS, or
both. All of this discussion indicates that there may be hundreds of different genomic variants
that can each contribute to an increased susceptibility to IBD.
The functional genomics of IBD susceptibility
A major limitation of GWAS is the assumption that common variants underlie the risk of dis-
ease in different families. The hypothesis-free GWA approach can drive understanding of new
areas of biology. Conversely, we have shown clearly in Fig 7 that a biological prior, based upon
transcriptional co-expression, in this case based upon expression and regulation in monocytes,
can focus analysis on a subset of genomic regions and specific candidate genes within those
regions, thereby reducing the false discovery rate and the genome-wide significance threshold.
Our hypothesis reduced the number of candidate genes/promoters analysed by two orders of
magnitude (around 2000 of 200,000 promoters). A previous study aimed at identifying gene
features linked to CD susceptibility noted the differential expression of genes associated with
“M1” versus “M2” macrophage activation states as a criterion [12]. The definition of those acti-
vation states is somewhat problematic [125,126]. We have taken a more nuanced view, with a
much more extensive dataset, to emphasise the specific importance of CSF1 and monocyte
differentiation.
NOD2 is amongst the most studied of loci underlying Crohn’s disease susceptibility, and
there are several protein-coding variants apparently linked to disease. However, there is little
consensus about NOD2 function in the GI tract and the mechanistic link between sequence
variants and disease susceptibility [127]. NOD2 mRNA is undetectable in either colon or small
intestine in the CAGE data, supporting the view that it is rapidly down-regulated during
monocyte differentiation to macrophages. NOD2 is believed to be expressed in Paneth cells,
and to influence their functions including production of defensins. If NOD2 is expressed in
Paneth cells, it is likely to be at a very low level, since Paneth cell markers such as DEFA6, and
stem cell markers such as LGR5, were easily detected in the total intestine mRNA. Our data
suggest that NOD2 is more likely to have a function in monocyte differentiation. Furthermore,
we suggest that NOD2 is not necessarily responsible for the genetic linkage on 16q, since the
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neighbouring genes, CYLD and SNX20 are tightly co-regulated and lie within the interval of
maximal association. The linkage to NOD2 is seen even in families where there is no coding
variation in NOD2, and an extended haplotype includes CYLD and the shared enhancer/pro-
moter region between SNX20/NOD2 [128]. Similarly, the case for biological roles of autophagy
in Crohn’s disease is also based upon linkage to a coding variant, T300A, in a key gene,
ATG16L1, but in this case also the link to function has been elusive [129] and the expression
and functional data suggest a more likely candidate in the neighbouring INPPP5D (SHIP1)
gene.
If macrophage differentiation in response to CSF1 is a key event in mucosal macrophage
anergy to intestinal flora, CSF1 itself, the alternate CSF1R ligand, IL34, and the receptor
CSF1R, would also be obvious candidate genes for IBD susceptibility. Two recent studies have
focused on elevated IL34 expression in IBD [130,131]. Both claim that IL34 is expressed in
uninflamed intestinal mucosa, but the FANTOM5 data indicate that the levels are very low.
The IL34 gene has two promoters, one expressed highly in skin and spleen, and the other in
brain, consistent with evidence from the mouse IL34 knockout that IL34 controls the develop-
ment of Langerhans cells and microglia [132]. Based upon the data herein, the elevated expres-
sion of IL34 mRNA and protein [130,131] in inflamed mucosa might actually be part of a
feedback control to dampen inflammation and initiate repair.
As noted above, CSF1R lies within 0.5MB of the IRGM locus linked with CD susceptibility
by GWA, and might potentially share upstream regulatory elements. Heterozygous mutation
in Csf1r has been shown to protect against pathology in a colitis model in mice [133]. There is
no evidence of association with IBD in the more immediate vicinity of CSF1R in the GWA
data, but one report based upon direct sequencing in a Acadian American population indi-
cated linkage to an intron 11 SNP [134]. Whole genome sequence data from 1000 genomes
and other sources (http://www.ensembl.org), and the recent human exome paper [135] also
reveal the existence of numerous likely loss-of-function alleles, with allele frequencies of 1/
1000 or more, within the intracellular tyrosine kinase domain of CSF1R. So, there may be rare/
private mutations in CSF1R that impact on IBD susceptibility. CSF1 was strongly induced in
MDM compared to monocytes, suggesting that these cells become autocrine. Variation in the
vicinity of an upstream enhancer at the CSF1 locus is very strongly linked to Paget’s disease
[136], and there is some evidence of association with UC at the same interval (S4 Table).
Given the complexity of the transcriptional regulation in monocytes and macrophages, and
the lack of robustness discussed above, it is not at all surprising that there are hundreds of
ways in which genetic variation can alter the sensitivity to environmental challenge, on the one
hand underlying infectious disease resistance, and on the other producing susceptibility to
IBD. Some of the genes discussed herein are expressed in both T cells and macrophages. For
some, it is clear that expression in macrophages is most relevant to the gut. Macrophage-spe-
cific conditional deletion of at least two IBD susceptibility loci, Il10ra [137] and Stat3 knockout
[138] has been shown to generate spontaneous colitis in mice. By contrast, in the case of Ship1
(Inppp5d), conditional deletion studies in mice suggest that ileitis present in the constitutive
knockout involves both myeloid and T cell dysfunction [101]. Many of the genes implicated in
Mendelian very early onset inflammatory bowel diseases (VEOIBD) (reviewed in [139,140])
such as all the components of the phagocyte NADPH oxidase system, are also highly-expressed
in blood monocytes. They include some, such as TTC7A,XIAP, BTK and MEFV that are
down-regulated by CSF1 and therefore meet our criteria. The FANTOM5 data provide a novel
insight into some VEOIBD loci. For example, both STXBP2 and DOCK8genes contain distinct
monocyte-specific promoters, and the latter also shows evidence of linkage to CD.
Current GWA hits still account for only a small proportion of the heritability in IBD. There
are likely to be epistatic interactions between susceptibility loci, which could explain some of
Macrophage transcriptional regulation and IBD susceptibility
PLOS Genetics | DOI:10.1371/journal.pgen.1006641 March 6, 2017 24 / 36
the apparently missing heritability [141]. On the other hand, rare coding variants that are spe-
cific to particular populations, that might have much larger effect, are invisible to GWA. A
recent example is a frame-shift mutation in the CSFR2B gene [142,143], also highly-expressed
in monocytes and regulated by CSF1 and LPS, associated with Crohn’s disease in Ashkenazi
Jews. Several groups have sought evidence of rare protein-coding variation within larger popu-
lations, with success limited in large measure by the lack of family-based inheritance data and
the lack of a biological hypothesis to prioritise variants [144–146] (reviewed in [6])
Identification of candidate genes within genomic intervals identified by GWA or direct
sequencing currently relies on programs such as GRAIL (Gene Relationships Across Impli-
cated Loci). Van Limbergen et al. [8] in a recent review, suggested that knowledge of the
genetic architecture of IBD has uncovered biological processes involved in IBD pathogene-
sis, but that new insights would require knowledge of regulation of transcription of key
genes and cell-type specific experiments. Our detailed reanalysis of all of the susceptibility
loci thus far identified in GWA support the view that the most relevant cell type to study is
the monocyte-macrophage and the prevalent candidate mechanism underlying specific
IBD susceptibility is a dysregulation of their differentiation in response to CSF1 and their
subsequent response to TLR agonists. Westra et al [61] identified candidate genes based
upon an eQTL analysis of blood transcriptional profiles. This is somewhat less sensitive
than our approach because monocytes are only a subset of the total blood cells. Neverthe-
less, supporting our hypothesis, 15/16 separate genes identified as both eQTL and associ-
ated with IBD by these authors were also repressed in MDM compared to monocytes and/
or induced by LPS in our dataset. Similarly, Fairfax et al. [47] described an eQTL analysis
of the response of human monocytes to LPS or IFNγ in which >80% of genes showed
genetic association under some condition, and associated a subset of those eQTL to CD
susceptibility loci; notably CARD9 (which is completely repressed by CSF1). As noted in
analysis of the entire FANTOM5 dataset [34,35], SNPs associated with promoters and
enhancers are strongly enriched for disease associations. The dataset we have created there-
fore provides a resource for identification and prioritization of SNPs that are likely to have
direct effects on gene expression and causal links to disease.
Conclusions
This monocyte-macrophage dysregulation hypothesis for IBD is based upon the specific prem-
ise that the differentiation of monocytes in response to CSF1, and their subsequent response to
LPS, is unique to the gut and the response to the gut microbiome. Clearly, there are also
aspects of T cell differentiation that are specific to the gut, for example the Th17 pathway, but
there is currently limited direct evidence that any variation in these functions is causally linked
to IBD susceptibility. Some of the T cell-associated genes and pathways are controlled by mac-
rophages and their products, including the many cytokines discussed above, so that there is
clearly the potential for pleiotropy. In general, variants that affect T cell activation would seem
likely to influence multi-system inflammatory disease susceptibility. Similarly, not all variants
that affect monocyte differentiation need impact solely on the gut. The obvious role of mono-
cytes in all forms of inflammation could provide an explanation for shared susceptibility loci
between IBD and other chronic inflammatory diseases [2], but Fig 7 shows clearly that the
CD-specific enrichment is not shared with RA. Our data indicate that the specific association
with differentiation in response to CSF1 and/or TLR ligands exemplified by LPS provides an
explanation for specific association with inflammation in the unique environment of the GI
tract. Of course, the advantage of this hypothesis is that is testable by comparing the transcrip-
tional profiles of MDM from patients and unaffected siblings. That will be a future direction.
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Methods
Cell culture
A full description of CAGE protocols was provided previously [34]. Ethical approval for the iso-
lation of cells from anonymous donors was granted by the University of Edinburgh Research
Ethics Committee. This study was reviewed by the University of Edinburgh College of Medicine
Ethics Committee (2009/01) and subsequently renewed by the Lothian Research Ethics Com-
mittee (11/AL/0168). Written informed consent was received from all volunteers participating
in the study. Blood samples from three donors were used. Peripheral blood mononuclear cells
were isolated from a single donation of 320ml of whole blood anticoagulated with acid-citrate-
dextrose, by Ficoll density gradient centrifugation. Monocytes were extracted using selection
for CD14-positive cells using antibodies on magnetic beads (MACS, Miltenyi Biotech). Mono-
cytes were plated in 6-well plates at 800,000 cells per well in complete media (RPMI containing
10% FCS, 20U/ml penicillin, 20 μg/ml streptomycin, and 2mM l-glutamine (Invitrogen)) with
100ng/ml recombinant human CSF-1 (a gift from Chiron Corp, Emeryville, CA) on tissue cul-
ture plastic for 7 days. Supplemental medium (50% of the volume in each well, containing
300ng/ml CSF-1) was added at day 5, and cells were used on day 7. Cells were treated with
10ng/ml bacterial lipopolysaccharide (LPS) from salmonella Minnesota R595 as described pre-
viously [21], and then harvested at time points from 15 minutes to 48 hours after treatment by
cell lysis, before RNA extraction using the Qiagen RNeasy kit (Qiagen, UK).
Gene and promoter expression analysis
CAGE library preparation and sequencing was carried out on each RNA sample, and clusters
of transcription start sites (CTSS) were identified by decomposition-based peak identification
as described [34]. The tag counts associated with CTSS meeting the FANTOM5 ‘robust’ crite-
ria (>200,000 CTSS) were quantified and normalized as described in [34]. As discussed previ-
ously, many human genes have multiple promoters, and they are numbered in the FANTOM5
dataset in order of relative abundance of detected CAGE tags. The majority of the analysis
herein is based upon quantification of individual promoters. Primary access to all of the FAN-
TOM5 data, including comparable mouse data, is available at http://fantom.gsc.riken.jp/
zenbu/
All of the primary data, including the normalized tag counts for each individual replicate at
every time point, can be visualized in Table form by accessing the ZENBU browser for the human
data directly at: http://fantom.gsc.riken.jp/zenbu/gLyphs/#config=dXO5cTaJBZiiw73fJq2oGD;
loc=hg19::chr17:34413143..34438026+
The link opens a specific locus in a genome browser. A search window can be used to move
to other loci based upon gene names or genomic interval. One track shows only the LPS time
course data. Another shows the entire FANTOM5 data set. The expression of individual pro-
moters can be highlighted and entire set of expression profiles across the primary FANTOM5
data is available for download from the site.
LPS time course analysis
In order to reduce noise arising from technical variation and biological differences between
cells from different volunteers, the expression value for each CTSS was compared to the
expression values of time points immediately before or after it, and the corresponding values
from the other two donors. Values deviating widely (>3SD) from the mean of this pool of 8
values were replaced with the average of the pool. An average expression value for each CTSS
from the three volunteers at each time point was then calculated. CTSS with a minimum
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expression level of 10 tags per million in at least one timepoint, and with a coefficient of
variation > 0.5, were included in expression analysis.
A pairwise coexpression network was generated using the Pearson correlation between
expression profiles for each CAGE-defined CTSS across the LPS timecourse. Correlations
were included where r 0.9. Coexpressed clusters were detected using the clustering algo-
rithm, MCL (MCLtools, www.micans.org; inflation value = 1.6). Heatmaps and line graphs of
expression data were created using the matplotlib library for Python 2.7.2. For the set of tran-
scription factor genes identified previously [34], total expression associated with all the pro-
moters was aggregated, the three replicates were averaged and only samples that had at least
one time point with 20 tags per million (TPM) were included in the analysis. Gene-based
expression data were clustered using BioLayout Express3D (http://biolayout.org). The network
was again based on correlations of r 0.9 between genes. A sample-to-sample Pearson corre-
lation for the pattern of transcription factor expression was calculated, and the resultant graph
with correlations of r 0.95 and an MCL inflation value of 2.2 was also displayed using Biolay-
out Express3D
Expression profiles of transcripts of named genes arising near genetic variants significantly
associated with Crohn’s disease were examined manually and are described in the text. Follow-
ing the observation that many of these named transcripts shared a similar pattern of expression
with NOD2, numerical criteria were determined, to describe the characteristics of this pattern.
Subsets of cell types were defined according to the groups in S2 Table. The following criteria
were determined a priori to describe the expression pattern observed:
• downregulated during monocyte differentiation to macrophage
(’unstimulated_monocyte>unstimulated_MDM’)
• specifically induced in interferon-stimulated monocytes (’IFN_monocyte>everythingelse’)
• specifically induced in monocytes after other inflammatory stimuli
(’inflammatory_monocyte>everythingelse’)
To assess the association of these candidates with IBD susceptibility, Crohn’s disease sum-
mary p-values were obtained from the International Inflammatory Bowel Disease Genetics
Consortium (ftp://ftp.sanger.ac.uk/pub4/ibdgenetics/cd-meta.txt.gz.). For comparison, we
applied the same criteria to loci putatively associated with ulcerative colitis [ftp://ftp.sanger.ac.
uk/pub4/ibdgenetics/ ucmeta-sumstats.txt.gz], rheumatoid arthritis [http://plaza.umin.ac.jp/~
yokada/datasource/software.htm] [147] and to a comparable size set of genes associated with
unrelated pathologies: the level of LDL cholesterol in blood [http://csg.sph.umich.edu/abecasis/
public/lipids2013/] [148], height [http://portals.broadinstitute.org/collaboration/giant/index.
php/GIANT_consortium_data_files] [149]. The ZENBU Browser cited above also shows indi-
vidual tracks for the p values for association of SNPs with each of the chosen traits, so that they
can be precisely aligned with enhancers and promoters within chosen loci.
For each of these studies, GWAS variants with p-values stronger than a permissive thresh-
old (p<1e-6) were counted in 1000 equally-sized bins above and below all TSS in the input set
(observed counts), and compared to the absolute count of all variants genotyped in the same
study in the same distance bins from all TSS in the input set (expected counts under the null
hypothesis that no enrichment exists). For Crohn’s disease, ulcerative colitis and the mixed
phenotype of inflammatory bowel disease, linkage disequilibrium score regression analyses
reveal strong evidence of polygenicity, supporting our decision to draw inferences from vari-
ants that do not meet stringent criteria for genome-wide significance. These analyses were
conducted by Bulik-Sullivan et al [150] using the same summary p-value data that we use here.
The ratio of observed:expected ratio was plotted for each bin (Fig 7). Summary p-values for
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this set of loci were computed using PASCAL [151] to calculate the total “burden of signifi-
cance” within a range of +/-100kb from each TSS region, for each GWAS study, and then to
quantify the probability of such a signal arising by chance using the PASCAL pathway enrich-
ment feature to compensate for linkage disequilibrium.
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